Want to see HK:2530 full AI Analyst Report?
Top Page
Numans Health Food Holdings Company Limited
(2530)
Select Model
Select Model
Rating:66Neutral
Price Target:
HK$0.78
▲(32.71% Upside)
Action:Reiterated
Date:09/23/26
The score is driven primarily by financial performance: a very conservative balance sheet and still-solid cash conversion are positives, but they are tempered by a sharp deterioration in revenue and profitability in the latest year. Valuation is a key offset (low P/E and ~3.45% yield), while technicals are neutral-to-slightly negative with limited trend strength.
Positive Factors
Conservative balance sheet
Extremely low leverage and a substantial equity base reduce solvency risk and preserve financial flexibility. This gives the company greater capacity to withstand weak trading conditions, maintain operations, and fund strategic needs without relying heavily on external borrowing.
Negative Factors
Sharp revenue contraction
A steep annual revenue decline signals a material deterioration in demand or business momentum, rather than normal quarter-to-quarter volatility. Unless sales recover, the smaller revenue base can reduce operating leverage and limit the company’s ability to rebuild earnings over coming periods.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage and a substantial equity base reduce solvency risk and preserve financial flexibility. This gives the company greater capacity to withstand weak trading conditions, maintain operations, and fund strategic needs without relying heavily on external borrowing.
Read all positive factors
Numans Health Food Holdings Company Limited (2530) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$720.00M
Dividend Yield3.47%
Average Volume (3M)458.40K
Price to Earnings (P/E)7.9
Beta (1Y)0.19
Revenue Growth-22.46%
EPS Growth72.17%
CountryHK
Employees50
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.08
Shares Outstanding1,000,000,000
10 Day Avg. Volume538,400
30 Day Avg. Volume458,400
Financial Highlights & Ratios
PEG Ratio-1.11
Price to Book (P/B)1.12
Price to Sales (P/S)3.00
P/FCF Ratio11.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Numans Health Food Holdings Company Limited Business Overview & Revenue Model
Company Description
Numans Health Food Holdings Company Limited focuses on the marketing, sale, and distribution of its Nemans-branded nutritional supplements across the People's Republic of China. Their extensive product range features algal oil docosahexaenoic acid...
How the Company Makes Money
null...
Numans Health Food Holdings Company Limited Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
83
Very Positive
Cash Flow
68
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 251.03M | 184.44M | 282.57M | 426.82M | 375.05M | 332.03M |
| Gross Profit | 156.17M | 122.78M | 210.81M | 316.17M | 274.05M | 239.01M |
| EBITDA | 19.84M | 14.05M | 101.40M | 194.32M | 118.40M | 157.89M |
| Net Income | 77.89M | 5.36M | 76.27M | 159.45M | 89.37M | 117.69M |
Balance Sheet | ||||||
| Total Assets | 552.40M | 513.74M | 415.59M | 470.02M | 403.58M | 288.81M |
| Cash, Cash Equivalents and Short-Term Investments | 444.41M | 401.65M | 235.82M | 262.56M | 192.84M | 152.66M |
| Total Debt | 4.99M | 3.77M | 4.43M | 5.83M | 7.45M | 1.23M |
| Total Liabilities | 44.01M | 18.40M | 39.07M | 59.94M | 156.34M | 86.29M |
| Stockholders Equity | 508.38M | 495.34M | 376.52M | 410.08M | 247.24M | 202.52M |
Cash Flow | ||||||
| Free Cash Flow | 56.87M | 46.71M | 82.33M | 149.95M | 39.42M | 93.00M |
| Operating Cash Flow | 57.07M | 46.75M | 83.46M | 150.57M | 44.31M | 93.99M |
| Investing Cash Flow | -117.64M | -37.02K | 2.04M | 1.57M | -4.14M | -519.00K |
| Financing Cash Flow | -76.07M | 116.27M | -113.48M | -83.79M | -8.55M | -29.31M |
Numans Health Food Holdings Company Limited Technical Analysis
Negative
0.59
Price Trends
0.73
Negative
0.73
Negative
0.65
Positive
Market Momentum
>-0.01
Negative
46.95
Neutral
56.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2530, the sentiment is Negative. The current price of 0.59 is below the 20-day moving average (MA) of 0.72, below the 50-day MA of 0.73, and below the 200-day MA of 0.65, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.95 is Neutral, neither overbought nor oversold. The STOCH value of 56.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2530.
Numans Health Food Holdings Company Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.88B | 7.74 | 18.48% | 5.25% | 33.56% | 59.06% | |
73 Outperform | HK$3.61B | 11.54 | 27.00% | 9.25% | 12.12% | 32.06% | |
66 Neutral | HK$720.00M | 7.88 | 15.52% | 3.47% | -22.46% | 72.17% | |
61 Neutral | HK$2.75B | 19.59 | 6.79% | 4.31% | -7.14% | 5.00% | |
60 Neutral | HK$13.09B | 15.01 | 11.77% | 4.83% | 24.27% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
HK:2530
Numans Health Food Holdings Company Limited
0.72
0.17
30.67%
HK:1112
Health and Happiness (H&H) International Holdings
20.28
7.92
64.01%
HK:6868
Tenfu (Cayman) Holdings Co
2.55
-0.38
-13.00%
HK:1837
Natural Food International Holding Ltd.
1.32
0.24
22.21%
HK:1497
Xiamen Yan Palace Bird's Nest Industry Co., Ltd. Class H
6.00
-1.05
-14.92%
HK:6980
Bama Tea Co. Ltd. Class H
26.78
-62.86
-70.12%
Numans Health Food Holdings Company Limited Corporate Events
Numans Health Food Swings to Strong Interim Profit Despite Revenue Decline
Aug 28, 2026
Numans Health Food Holdings Company Limited reported interim unaudited results for the six months ended 30 June 2026, showing revenue of RMB72.7 million, down from RMB93.2 million a year earlier. The health food group nevertheless delivered a shar...
Numans Health Food shifts Hong Kong principal office to Wan Chai
Aug 24, 2026
Numans Health Food Holdings Company Limited has relocated its principal place of business in Hong Kong to Suite 2407 on the 24th floor of China Resources Building on Harcourt Road in Wan Chai, effective 24 August 2026. While telephone and facsimil...
Numans Health Food Sets August Board Meeting to Approve Interim Results
Aug 17, 2026
Numans Health Food Holdings Company Limited has scheduled a board meeting for 28 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider the possible recommendation of an interim di...
Numans Health Food Signals Higher Profit on Lower Revenue in Supplemental Alert
Aug 14, 2026
Numans Health Food Holdings Company Limited has issued a supplemental positive profit alert, indicating that while revenue from its nutritional products business fell to about RMB72.7 million from RMB93.2 million year-on-year, profit for the perio...
Numans Health Food Flags Surge in Interim Profit on Investment Gains
Aug 13, 2026
Numans Health Food Holdings Company Limited has warned investors of a sharp jump in interim profit, with the group expecting net profit of about RMB48.9 million for the six months ended 30 June 2026, compared with RMB2.1 million a year earlier. Th...
Numans Health Food Wins Waiver on Circular Delay for Further Acquisitions
Jul 16, 2026
Numans Health Food Holdings Company Limited has secured a waiver from strict compliance with Rule 14.41(a) of the Hong Kong Listing Rules, allowing additional time to finalize financial information required for a circular on its planned further ac...
Numans Health Food Details Auditor Change and Delay in 2025 Results
Jul 9, 2026
Numans Health Food Holdings Company Limited has detailed the timeline and circumstances surrounding its change of auditor and the resulting delay in publishing its 2025 annual results. The company explained that Crowe, appointed as auditor in Sept...
Numans Health Food delays acquisition circular, seeks waiver on disclosure deadline
Jul 6, 2026
Numans Health Food Holdings Company Limited has announced a delay in sending a shareholder circular relating to its further acquisitions, which together with previous deals amount to a major transaction under Hong Kong listing rules. The company s...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.